[Seite 34↓]

Literatur

Amareld Jr. RW, Wersocki M, Drohan M, Drohan WN, Burgess WH, Mann DM Forng RY (2003) Controlled gamma-irradiation mediated pathogen inactivation of human urokinase preparations with significant recovery of enzymatic activity. Biologicals 31(4): 261-264.

Anderson SM, Gocke D, Belzer SW, Gamble A, Campanella C, Bankowski MJ (2003) Detection of Hepatitis C Virus RNA in Cadaveric Serum or Plasma samples Using Nucleic Acid Amplification. Abstract S-1, 27th Annual Meeting, American Association of Tissue Banks, San Diego, CA, USA, August 23-27.

Arbeitskreis Blut des Bundesministeriums für Gesundheit (2000) Humanes Cytomegalievirus (HCMV). Stellungnahme des AK Blut, Untergruppe „Bewertung Blut-assoziierter Krankheitserreger“ vom 09.05.2000, www.rki.de.

Bankowski MJ (2002) Microbiology Practices in Recovery and Testing. 26th Annual Meeting, American Association of Tissue Banks, Boston, MA, USA, August 23-27, 2002

Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-71.

Bräuniger S, Peters J, Borchers U, Kao M (2000) Further studies on thermal resistance of bovine parvovirus against moist and dry heat. Int J Hyg Environ Health 203(1): 71-75.

Bundesärztekammer – Wissenschaftlicher Beirat (2001) Richtlinien zum Führen einer Knochenbank. Deutsches Ärzteblatt 98(15): A1011-1016.

Bein G, Sachs U (2003) Unerwünschte Wirkungen. In: Bundesärztekammer - Wissenschaftlicher Beirat (Hrsg.) Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten, Deutscher Ärzte-Verlag, Köln, pp. 259-282.

Bundesärztekammer - Wissenschaftlicher Beirat, Paul-Ehrlich-Institut (2000) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Deutscher Ärzte-Verlag, Köln.

Bundesgesetzblatt (1998) Gesetz über den Verkehr mit Arzneimitteln – Arzneimittelgesetz (AMG). Fassung vom 11. Dezember 1998, BGBl. I 1998: 3586.

Bundesinstitutes für Arzneimittel und Medizinprodukte (BfArM) und Paul-Ehrlich-Institut (PEI) (1994) Anforderungen an Validierungsstudien zum Nachweis der Virussicherheit von Arzneimitteln aus menschlichem Blut oder Plasma. Bundesanzeiger 84: 4742-4744.

Busch MP (2003) Infectious Risks of Blood Transfusions: Known Viruses and Future Threats. 27th Annual Meeting, American Association of Tissue Banks, San Diego, CA, USA, August 23-27.

Campbell DG, Li P (1999) Sterilisation of HIV with irradiation: Relevance to infected bone allografts. Aust N Z J Surg 69: 517-521.

Caspari G, Gerlich WH (2003) Durch Blut übertragbare Infektionskrankheiten. In: Mueller-Eckhardt C, Kiefel V (Hrsg.) Transfusionsmedizin, Grundlagen – Therapie – Methodik. 3. überarbeitete und erweiterte Auflage, Springer, Berlin, Heidelberg, New York, pp. 599-645.

CDC, Center for Disease Control and Prevention (1987) Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft. MMWR 36(21): 324-325.

CDC, Center for Disease Control and Prevention (1988) Transmission of HIV through bone transplantation: case report and public health recommendations. MMWR 37: 597-599.

CDC, Center for Disease Control and Prevention (1989) Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. MMWR 38(3): 37-38.

CDC, Center for Disease Control and Prevention (2002) Update: Allograft-Associated Bacterial Infections. MMWR 51(10): 207-210.

CDC, Center for Disease Control and Prevention (2003) Hepatitis C Virus Transmission from an Antibody-Negative Organ and Tissue Donor. MMWR 52(13): 273-276.

CEN, Comité Européen de Normalisation (1994) Sterilization of medical devices utilizing tissues-validation of the inactivation of viruses and other transmissible agents. 316/WG3/N-02, Delft, Netherlands.

Clavero MR, Monk JD, Beuchat LR, Doyle MP, Brackett RE (1994) Inactivation of Escherichia coli O157:H7, salmonellae and Campylobacter jejuni in raw ground beef by gamma irradiation. Appl Environ Microbiol 60(6) : 2069-2075.

Conrad EU, Gretch DR, Obermeyer KR, Moogk MS, Sayers M, Wilson JJ, Strong DM (1995) Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am 77(2): 214-224.

Dziedzic-Goclawska A (2003) persönliche Mitteilung.

EAEMP, European Agency for the Evaluation of Medicinal Products (1996) Note for guidance on virus validation studies: The design, contribution and interpretation of studies validating the inactivation and removal of viruses. Committee for Proprietary Medicinal Products (CPMP), CPMP/BWP/268/95, London, UK.

Eastlund T (2002) Tissue Transplant-Transmitted Bacterial Infections: AATB Investigation. AATB Quality Assurance Workshop IV, New Orleans, LA, USA, November 13-14.

EATB/EAMST (1997) Common standards for musculo skeletal tissue banking. OBIG-Transplant, Vienna, Austria.

Fideler BM, Vangness T, Moore T, Li Z, Rasheed S (1994) Effects of gamma irradiation on the human immunodeficiency virus. A study in frozen human bone-patellar ligament-bone grafts obtained from infected cadavera. J Bone Joint Surg Am 76(7): 1032-1035.

Forsell JH, Liesman J (2000) Analysis of potential causes of positive microbiological cultures in tissue donors. Cell and Tissue Banking 1: 111-115.

Graul A, Heiden M, Gräf K, Keller-Stanislawski (2003) Hämovigilanz in Deutschland – Berichte an das Paul-Ehrlich-Institut über Verdachtsfälle von Transfusionsreaktionen im Beobachtungszeitraum Januar 1995 bis Dezember 2002. Transfus Med Hemother 30: 232-238.

Grieb T, Forng RY, Brown R, Owolabi T, Maddox E, Mc Bain A, Drohan WN, Mann DM, Burgess WH (2002) Effective use of Gamma Irradiation for Pathogen Inactivation of Monoclonal Antibody Preparations. Biologicals 30: 207-216.

Hahn H, Falke D, Kaufmann SHE, Ullmann U (2001) Medizinische Mikrobiologie und Infektiologie. 4. Auflage, Springer-Verlag, Berlin, Heidelberg, New York.

Hernigou P, Gras G, Marinello G, Dormont D (2000) Influence of irradiation on the risk of transmission of HIV in bone grafts obtained from appropriately screened donors and followed by radiation sterilization. Cell and Tissue Banking 1(4): 279-289.

Hilmy N, Febrida A, Basril A (2000) Validation of Radiation Sterilization Dose for Lyophilized Amnion and Bone Grafts Cell and Tissue Banking 1(2): 143-148.

IAEA, International Atomic Energy Agency (1990) Sterility Assurance Level. In: Guidelines for Industrial Radiation Sterilization of Disposable Medical Products (Cobalt-60 Gamma Irradiation). IAEA, TECDOC-539, Vienna, Austria.

IAEA, International Atomic Energy Agency (2002) Code of Practice for the Radiation Sterilization of Tissue Allografts: Requirements for Validation and Routine Control. Preliminary version, August 2002, Boston, MA, USA.

James JIP (1953) Tuberculosis transmitted by bone bank. J Bone Joint Surg Br 35 : 578.

Joyce MJ, Greenwald AS, Mowe J, Kennedy J, Toohey D, Heim CS, Rosier RN, Wong D (2003) Musculoskeletal Allograft Tissue Safety. Tissue Work Group, 70th Annual Meeting of the American Academy of Orthopaedic Surgeons, New Orleans, LA, USA, February 5-9.

Knaepler H, von Garrel T, Gotzen L (1994) Untersuchungen zur Desinfektion und Sterilisation allogener Knochentransplantate. Hefte Z Unfallchir 235: 1-101

Knaepler H, von Garrel T, Seipp HM, Ascherl R (1992) Experimentelle Untersuchungen zur thermischen Desinfektion und Sterilisation allogener Knochentransplantate und deren Auswirkungen auf die biologische Wertigkeit. Unfallchirurg 95: 477-484.

Koenigbauer UF, Eastlund T, Day JW (2000) Clinical Illness Due to Parvovirus B19 Infection after Infusion of Solvent/Detergent-Treated Pooled Plasma. Transfusion 40: 1203-1206.

Kuner EH, Schlickewei W, Huber-Lang M, Schaefer DJ, Laubenberger J (1998) Über die Verwendung autoklavierter Spongiosa. Unfallchirurg 101: 870-876.

Lelie PN, van Drimmelen HAJ, Cuypers TM, Best SJ, Stramer SL, Hyland C, Allain JP, Moncharmont P, Defer C, Nübling M, Glauser A, da Silva Cardosos M, Viret JF, Lankinen MH, Grillner L, Withmüller U, Coste J, Schottstedt V, Masecar B, Dax EM (2002) Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion 42: 527-536.

Levartovsky S, Lazarovich A (2002) Devastating endophtalmitis caused by Serratia marcescens in two recipients after transplantation of corneal grafts from the same donor. Cell and Tissue Banking 3: 45-47.

Liu JW, Chao LH, Su LH, Wang JW, Wang CJ (2002) Experience with a bone bank operation and allograft bone infection in recipients at medical centre in southern Taiwan. J Hosp Infect 50: 293-297.

Lomas R, Drummond O, Kearney JN (2000) Processing of whole femoral head allografts: A method for improving clinical efficacy and safety. Cell and Tissue Banking 1: 193-200.

Lord CF, Gebhardt MC, Tomford WW, Mankin HJ (1988) Infection in Bone Allograft. Incidence, Nature, and Treatment. J Bone Joint Surg Am 70(3): 369-376.

Mahnel H (1979) Resistenzunterschiede zwischen Viren verschiedener Gruppen gegenüber einigen chemisch-physikalischen Dekontaminationsverfahren. Infection 7(5): 240-246.

Martinez O (2002) Microbiologic Screening of Cadaver Donors and Tissues for Transplantation. 26th Annual Meeting, American Association of Tissue Banks, Boston, MA, USA, August 23-27, 2002.

Matsui H, Sugimoto M, Shizuko Tsuij S, Shima M, Giddings J, Yoshioka A (1999) Transient Hypoplastic Anaemia Caused by Primary Human Parvovirus B19 Infection in a Previously Untreated Patient with Haemohilia Transfused with a Plasma-Derived, Monoclonal Antibody-Purified Factor VIII Concentrate. J Paed Haem Onc 2(1): 74-76.

Meisel H, Endres AS, Walther HU, Wend UC, Gerlich WH (2003) Transmission of Hepatitis B Virus 2 Months prior to Hepatitis Surface Antigen Positivity of Donor Blood. Transfus Med Hemother 30: 228-231.

Modrow S, Falke D (1998) Molekulare Virologie. Spektrum Akademischer Verlag, Heidelberg, Berlin, Oxford.

Müller-Breitkreuz K (2000) Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997. Vox Sang 78: 149-157.

Nielsen HT, Larsen S, Andersen M, Ovesen O (2001) Bone bank service in Odense, Denmark. Audit of the first ten years with bone banking at the Department of Orthopaedics, Odense University Hospital. Cell and Tissue Banking 2: 179-183.

Offergeld R, Stark K, Hamouda O (2003) Infektionen bei Blutspendern. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 46: 775-779.

Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497-500.

Pruss A, Jacker HJ, Borchert HH, Seibold M, von Versen R (2003) Peracetic Acid-Ethanol Treatment of Bone Allografts – a Reliable Sterilization Method. Abstract S-22, 27th Annual Meeting, American Association of Tissue Banks, San Diego, CA, USA, August 23-27.

Pruss A, Kao M, Gohs U, Koscielny JK, von Versen R, Pauli G (2002) Effects of gamma irradiation on human cortical bone transplants contaminated with enveloped and non-enveloped viruses. Biologicals 30: 205-213.

Pruss A, Perka C, Degenhardt P, Maronna U, Büttner-Janz K, Paul B, Müller K, Klumpp C, Bruck JC, von Versen R (2002) Clinical Efficacy and Compatibility of Allogeneic Avital Tissue Transplants Sterilized with a Peracetic Acid/Ethanol Mixture. Cell and Tissue Banking 3(4): 235-243.

Pruss A (2004) Virus inactivation. In: Phillips GO (ed.) Proceedings of the IAEA: Expert meeting on sterilisation using ionising irradiation. Cellulon Trust, Wrexham, UK, in press.

Rajkowski KT, Boyd G, Thayer DW (2003) Irradiation D-values for Escherichia coli O157:H7 and Salmonella sp. on inoculated broccoli seeds and effects of irradiation on broccoli sprout keeping quality and seed viability. J Food Prot 66(5): 760-766.

Regel G, Südkamp NP, Illgner A, Buchenau A, Tscherne H (1992) 15 Jahre allogene Knochentransplantation. Unfallchirurg 95: 1-8.

RKI, Robert Koch Institut (2002) Prävention von HIV-Infektionen. Epidemiologisches Bulletin 48: 401-405.

Salai M, Vonsover A, Pritch M, von Versen R, Horoszowski H (1997) Human immunodeficiency virus (HIV) inactivation of banked bone by gamma irradiation. Ann Transplant 2: 55-56.

Saleh YG, Mayo MS, Ahearn DG (1988) Resistance of Some Common Fungi to Gamma Irradiation. Appl Environ Microbiol 54(8): 2134-2135.

Sanzén L, Carlsson A (1997) Transmission of human T-cell lymphotrophic virus type 1 by a deep-frozen bone allograft. Acta Orthop Scand 68(1): 72-74.

Schratt HE, Regel G, Kiesewetter B, Tscherne H (1996) HIV-Infektion durch kältekonservierte Knochentransplantate. Unfallchirurg 99: 679-684.

Schüttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S (2000) Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 355: 41-42.

Seifried E, Findhammer S, Roth WK (2002) Status of NAT screening for HCV, HIV and HBV – Experiences of the German Red Cross Blood Donation Services. In: Brown F, Seitz R (Hrsg.): Advances in Transfusion Safety. Dev Biol 108, Karger, Basel, pp. 23-27.

Shutkin NM (1954) Homologous-serum hepatitis following the use of refrigerated bone-bank bone. J Bone Joint Surg 36A: 160-162.

Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley LJ, Kohlenberg SH, Castro KG, Dahan BA, Schable CA, Rayfield MA, Rogers MF (1992) Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 326(11): 726-732.

Spire B, Dormont D, Barre-Sinoussi F, Montagnier L, Cherman JC (1985) Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet 1 (8422): 188-189.

Strong DM (2003) NAT for Cadaveric Donors. 27th Annual Meeting, American Association of Tissue Banks, San Diego, CA, USA, August 23-27.

Sutherland AG, Raafat A, Yates P, Hutchison JD (1997) Infection associated with the use of allograft bone from the North East Scotland Bone Bank. J Hosp Infect 35(3): 215-222.

Tomford WW, Starkweather RJ, Goldman MH (1981) A study of the clinical incidence of infection in the use of banked allograft bone. J Bone Joint Surg Am 63(2): 244-248.

Tomford WW, Thongphasuk J, Mankin HJ, Ferraro MJ (1990) Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg Am 72(8): 1137-1143.

Tomford WW (1995) Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am 77(11): 1742-1754.

Tomford WW (2003) Clinical experience of radiation effects with structural and non-structural grafts. IAEA International High Level Expert Meeting ´Sterilization of Tissues using Ionising Radiations´ Wrexham, Wales UK, September 1-5.

Tomono T (2002) Status of NAT Screening for HCV, HIV and HBV: Experience in Japan. In: Advances in Transfusion Safety . Brown F, Seitz R (eds.) Dev Biol, Basel, Karger, 108: 29-39.

Urist MR, Strates BS (1971) Bone morphogenetic proteins. J Dent Res 50(6): 1392-1406.

von Garrel T (2003) Persönliche Mitteilung auf der Grundlage einer Befragung von 1.400 chirurgischen/orthopädischen Kliniken in Deutschland aus dem Jahr 2001.

von Versen R, Heider H, Kleemann I, Starke R (1992) Chemische Sterilisation biologischer Implantate mit einer Kombinationsmethode. In: Pesch HJ, Stöß H, Kummer B (Hrsg.) Osteologie aktuell, Springer-Verlag, 7(suppl.): 380–386.

Wallhäußer KH (1995) Praxis der Sterilisation - Desinfektion - Konservierung - Keimidentifizierung - Betriebshygiene. 5. Aufl., Georg Thieme Verlag, Stuttgart.

Weusten JJAM, van Drimmelen HAJ, Lelie PN (2002) Mathematic modeling of the risk for HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion 42: 537-548.

WHO, World Health Organization – Health Technology and Pharmazeutical Cluster (2003) Guidelines on Transmissible Spongiform Encephalopathies in relation to Biological and Pharmaceutical Products. WHO/BCT/QSD/03.01. Geneva, Switzerland.

Wippermann BW, Schratt HE, Steeg S, Tscherne H (1997) Complications of spongiosa harvesting of the ilial crest. A retrospective analysis of 1,191 cases. Chirurg 68(12): 1286-1291.

Wutzler P, Sauerbrei A (2000) Virucidal efficacy of a combination of 0.2% peracetic acid and 80% (v/v) ethanol (PAA-ethanol) as a potential hand disinfectant. J Hosp Infect 46: 304-308.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
15.02.2005